Retrospective evaluation of toceranib phosphate (Palladia) in cats with oral squamous cell carcinoma.


Objectives The aim of the study was to determine the clinical benefit and adverse event profile of toceranib phosphate in the treatment of feline oral squamous cell carcinoma (FOSCC). Methods Data obtained from the medical records of cats with oral squamous cell carcinoma diagnosed between 2010 and 2014 treated with toceranib phosphate were compared with… (More)
DOI: 10.1177/1098612X15622237

10 Figures and Tables


  • Presentations referencing similar topics